Christine Flarup Møller-Jensen

Christine is Senior Vice President, Novo Nordisk with a track record of leading change and delivering im-pact. Christine has end-to-end understanding of the biotech and medtech value chain and broad knowledge of pharmaceutical and business ethics regulations. Christine was member of DTU Advisory board and board of Representatives from 2008 to 2014.